SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-004934
Filing Date
2021-04-27
Accepted
2021-04-27 16:53:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20210427xdefa14a.htm DEFA14A 27293
2 GRAPHIC tmb-20210427xdefa14a001.jpg GRAPHIC 145565
3 GRAPHIC tmb-20210427xdefa14a002.jpg GRAPHIC 103061
  Complete submission text file 0001558370-21-004934.txt   370916
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39746 | Film No.: 21859716
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences